Pay in 4 interest-free payments of $6.90 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
The World Obesity Federation (WOF) is projecting that obesity prevalence across Asia Pacific will increase by more than 40 percent by 2035, indicating a rapidly expanding treatment-eligible population that remains largely underserved by pharmacological interventions
In comparison, Semaglutide , which you may know as Wegovy (or Ozempic for diabetes), results in around 16% weight loss
the figures above come from Lillys December 2025 press release
Plushcare Reviews: Weight Loss & GLP-1 Most of the telehealth platforms for GLP-1 are medication delivery services in disguise as medical providers
Malabsorption issues
US$ 21.71
US$ 27.22
US$ 29.28
US$ 26.00
US$ 25.25
